{"id":94,"date":"2025-01-20T15:11:42","date_gmt":"2025-01-20T15:11:42","guid":{"rendered":"https:\/\/peanutimmunotherapy.scot\/?p=94"},"modified":"2025-01-20T15:12:12","modified_gmt":"2025-01-20T15:12:12","slug":"safety-of-peanut-oit-in-young-children-in-a-clinic-setting","status":"publish","type":"post","link":"https:\/\/peanutimmunotherapy.scot\/?p=94","title":{"rendered":"Safety of peanut OIT in young children in a clinic setting"},"content":{"rendered":"\n<p><a href=\"https:\/\/doi.org\/10.1186\/s13223-024-00916-5\">Study from Canada <\/a>&#8211; 69 children under the age of 3 reached maintenance dose of peanut over a median of 29\u00a0weeks (so slightly more than 6 months, on average). <\/p>\n\n\n\n<p>One patient had a peanut ingestion-related emergency department (ED) visit requiring adrenaline during initial dose escalation (first day). <\/p>\n\n\n\n<p>During the first year of maintenance phase, no patients had peanut ingestion-related ED visits nor required adrenaline.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Study from Canada &#8211; 69 children under the age of 3 reached maintenance dose of peanut over a median of 29\u00a0weeks (so slightly more than 6 months, on average). One patient had a peanut ingestion-related emergency department (ED) visit requiring adrenaline during initial dose escalation (first day). During the first year of maintenance phase, no [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9,8],"tags":[],"class_list":["post-94","post","type-post","status-publish","format-standard","hentry","category-research","category-under-4s"],"_links":{"self":[{"href":"https:\/\/peanutimmunotherapy.scot\/index.php?rest_route=\/wp\/v2\/posts\/94","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/peanutimmunotherapy.scot\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/peanutimmunotherapy.scot\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/peanutimmunotherapy.scot\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/peanutimmunotherapy.scot\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=94"}],"version-history":[{"count":2,"href":"https:\/\/peanutimmunotherapy.scot\/index.php?rest_route=\/wp\/v2\/posts\/94\/revisions"}],"predecessor-version":[{"id":96,"href":"https:\/\/peanutimmunotherapy.scot\/index.php?rest_route=\/wp\/v2\/posts\/94\/revisions\/96"}],"wp:attachment":[{"href":"https:\/\/peanutimmunotherapy.scot\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=94"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/peanutimmunotherapy.scot\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=94"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/peanutimmunotherapy.scot\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=94"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}